This project, a partnership with pharmaceutical company Pfizer, Inc., is developing a theory-based, in-clinic component to improve breast and cervical cancer outcomes by helping Hispanic/Latina patients “navigate” the many health care choices and actions they have to address screening abnormalities. Using qualitative and quantitative methods and comparison, as well as treatment sites, the study will monitor and evaluate critical elements of healthcare access that occur during treatment and the first 12 months of survivorship, starting at diagnosis.
Two community clinics, part of the University Family Health Center and managed by The University of Texas Health Science Center at San Antonio, in a low-income Hispanic barrio in South San Antonio.
The study, which began implementation in March 2006, has recruited more than 90 women thus far, nearing its recruitment goal of 58 in an intervention group and 58 in a control group. In the end, the result is expected to be a model of cancer care that can be replicated and disseminated in other communities where Hispanic women confront significant disparities in cancer health care delivery. The proposed breast and cervical cancer patient navigator program represents a new area of research that is being actively promoted by the NCI and CDC, and it complements Pfizer’s concept of a research-anchored foundation of care that identifies barriers to care that lead to interventions that improve health outcomes.